Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA
Clinical trial NCT05766969 · UNKNOWN
Trial details
- NCT number
- NCT05766969
- Sponsor
- Pure Green Pharmaceuticals Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2023-12-05
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.